Latest Financial Performance News

Vicinity Centres reported a robust FY25 with statutory net profit surging to $1 billion, driven by strategic portfolio repositioning and strong retail sales growth. The company’s focus on premium assets and disciplined capital management sets the stage for continued growth in FY26.

Saunders International reported a sharp 77.9% drop in net profit for FY2025, even as revenue dipped only slightly by 0.7%. The company declared a final dividend, signaling cautious optimism amid earnings pressure.

Vicinity Centres reported a doubling of net profit and delivered funds from operations at the top of guidance, underpinned by strategic acquisitions and strong portfolio performance.

Vicinity Centres has reported a robust increase in revenue and net profit for FY25, alongside a steady distribution payout to securityholders. The company’s financial health shows promising resilience amid a competitive real estate market.

VGI Partners Global Investments Limited reported a $17.6 million net loss for FY25 but maintained its dividend policy and executed a $73 million share buy-back, signaling confidence amid market challenges.

Magellan Financial Group reported a 31% drop in net profit after tax for FY25, yet operating profit rose 5%, supported by strategic partnerships and an 8.2% increase in assets under management. The Board declared a special fully franked dividend, signaling confidence in future earnings.

Monash IVF Group has completed an independent review into two separate clinic incidents involving non-standard IVF treatments, revealing human errors and IT system issues. The company commits to enhanced safeguards without expecting significant financial impact.

Vicinity Centres reported a robust FY25 with statutory net profit soaring to $1 billion, driven by strategic portfolio repositioning and strong leasing momentum. The company’s focus on premium retail assets and key developments underpin a cautiously optimistic outlook for FY26.

Schaffer Corporation Limited reported a 1.5% increase in revenue to $229.7 million for FY2025, despite a 10.3% decline in net profit to $24.3 million. The company declared a fully franked final dividend of 45 cents per share, maintaining total dividends at 90 cents for the year.

Lycopodium Limited delivered robust FY25 financial results, hitting the top end of guidance with $339.6 million revenue and $42.2 million net profit. The company’s strategic SAXUM acquisition broadens its footprint in the Americas, positioning it well for growth in critical minerals and clean energy sectors.

Pharmx Technologies reported a 13% increase in FY25 revenues to $7.53 million, driven by strong growth across its Gateway and Marketplace platforms. The company maintained positive EBITDA and a solid cash position despite legal expenses, setting the stage for an ambitious FY26 growth strategy.

Vicinity Centres reported a robust FY25 with statutory net profit surpassing $1 billion and Funds From Operations reaching the top end of guidance, underpinned by strategic asset acquisitions and strong portfolio performance.